Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity

被引:351
作者
de Andrade, Lucas Ferrari [1 ,2 ]
Tay, Rong En [1 ,2 ]
Pan, Deng [1 ,2 ]
Luoma, Adrienne M. [1 ,2 ]
Ito, Yoshinaga [1 ,2 ]
Badrinath, Soumya [1 ,2 ]
Tsoucas, Daphne [3 ]
Franz, Bettina [1 ,2 ]
May, Kenneth F., Jr. [4 ]
Harvey, Christopher J. [1 ]
Kobold, Sebastian [1 ]
Pyrdol, Jason W. [1 ]
Yoon, Charles [4 ,5 ]
Yuan, Guo-Cheng [3 ]
Hodi, F. Stephen [4 ]
Dranoff, Glenn [4 ,6 ]
Wucherpfennig, Kai W. [1 ,2 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Immunol & Virol, 450 Brookline Ave, Boston, MA 02215 USA
[2] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Biostat & Computat Biol, 450 Brookline Ave, Boston, MA 02215 USA
[4] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA
[5] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA
[6] Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA
关键词
I-RELATED CHAIN; NKG2D RECEPTOR; T-CELLS; CUTTING EDGE; LIGANDS; EXPRESSION; ACTIVATION; CANCER; CYTOTOXICITY; MOLECULES;
D O I
10.1126/science.aao0505
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MICA and MICB are expressed by many human cancers as a result of cellular stress, and can tag cells for elimination by cytotoxic lymphocytes through natural killer group 2D (NKG2D) receptor activation. However, tumors evade this immune recognition pathway through proteolytic shedding of MICA and MICB proteins. We rationally designed antibodies targeting the MICA alpha 3 domain, the site of proteolytic shedding, and found that these antibodies prevented loss of cell surface MICA and MICB by human cancer cells. These antibodies inhibited tumor growth in multiple fully immunocompetent mouse models and reduced human melanoma metastases in a humanized mouse model. Antitumor immunity was mediated mainly by natural killer (NK) cells through activation of NKG2D and CD16 Fc receptors. This approach prevents the loss of important immunostimulatory ligands by human cancers and reactivates antitumor immunity.
引用
收藏
页码:1537 / +
页数:6
相关论文
共 36 条
[1]   A 2ND LINEAGE OF MAMMALIAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I GENES [J].
BAHRAM, S ;
BRESNAHAN, M ;
GERAGHTY, DE ;
SPIES, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6259-6263
[2]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[3]   Cutting Edge: The Metalloproteinase ADAM17/TNF-α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein [J].
Boutet, Philippe ;
Agura-Gonzalez, Sonia ;
Atkinson, Susan ;
Pennington, Caroline J. ;
Edwards, Dylan R. ;
Murphy, Gillian ;
Reyburn, Hugh T. ;
Vales-Gomez, Mar .
JOURNAL OF IMMUNOLOGY, 2009, 182 (01) :49-53
[4]   Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion [J].
Bryceson, YT ;
March, ME ;
Ljunggren, HG ;
Long, EO .
BLOOD, 2006, 107 (01) :159-166
[5]   Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17 [J].
Chitadze, Guranda ;
Lettau, Marcus ;
Bhat, Jaydeep ;
Wesch, Daniela ;
Steinle, Alexander ;
Fuerst, Daniel ;
Mytilineos, Joannis ;
Kalthoff, Holger ;
Janssen, Ottmar ;
Oberg, Hans-Heinrich ;
Kabelitz, Dieter .
INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (07) :1557-1566
[6]   Human tumor-derived exosomes down-modulate NKG2D expression [J].
Clayton, Aled ;
Mitchell, J. Paul ;
Court, Jacquelyn ;
Linnane, Seamus ;
Mason, Malcolm D. ;
Tabi, Zsuzsanna .
JOURNAL OF IMMUNOLOGY, 2008, 180 (11) :7249-7258
[7]   A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection [J].
Deng, Weiwen ;
Gowen, Benjamin G. ;
Zhang, Li ;
Wang, Lin ;
Lau, Stephanie ;
Iannello, Alexandre ;
Xu, Jianfeng ;
Rovis, Tihana L. ;
Xiong, Na ;
Raulet, David H. .
SCIENCE, 2015, 348 (6230) :136-139
[8]   Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells [J].
Gao, Yulong ;
Souza-Fonseca-Guimaraes, Fernando ;
Bald, Tobias ;
Ng, Susanna S. ;
Young, Arabella ;
Ngiow, Shin Foong ;
Rautela, Jai ;
Straube, Jasmin ;
Waddell, Nic ;
Blake, Stephen J. ;
Yan, Juming ;
Bartholin, Laurent ;
Lee, Jason S. ;
Vivier, Eric ;
Takeda, Kazuyoshi ;
Messaoudene, Meriem ;
Zitvogel-, Laurence ;
Teng, Michele W. L. ;
Belz, Gabrielle T. ;
Engwerda, Christian R. ;
Huntington, Nicholas D. ;
Nakamura, Kyohei ;
Hoelzel, Michael ;
Smyth, Mark J. .
NATURE IMMUNOLOGY, 2017, 18 (09) :1004-+
[9]   The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor [J].
Gasser, S ;
Orsulic, S ;
Brown, EJ ;
Raulet, DH .
NATURE, 2005, 436 (7054) :1186-1190
[10]   Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation [J].
Groh, V ;
Wu, J ;
Yee, C ;
Spies, T .
NATURE, 2002, 419 (6908) :734-738